The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia-Reference-Cited by-同舟云学术

The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia

Published:2020-11-16 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Zhu Hong-Hu

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference46 articles.

1. The clinical report of 16 long-term survivors of acute promyelocytic leukemia treated with Ai-Ling 1 and traditional Chinese medicine;Sun;Inf Tradit Chin Med,1991

2. Seven years’ summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide–an analysis of 242 cases;Zhang;Zhonghua Xue Ye Xue Za Zhi,2000

3. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report;Lu;Blood,2002

4. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity;Mathews;Blood,2006

5. Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy;Ghavamzadeh;Ann Oncol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Inhibitory Effect on Tumor Cells Proliferation Induced by Arsenic Through DNMTs and its Downstream Molecules: A Systematic Review and Meta-Analysis;Current Pharmaceutical Design;2022-09

2. Synthesis and Antileukemia Activity Evaluation of Benzophenanthridine Alkaloid Derivatives;Molecules;2022-06-19

3. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic;Frontiers in Bioengineering and Biotechnology;2021-09-07

4. Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia;Cancer Management and Research;2021-05